Estrogen-related receptor α regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway

被引:45
|
作者
Murray, Jennifer [1 ]
Huss, Janice M. [1 ]
机构
[1] City Hope Natl Med Ctr, Div Gene Regulat & Drug Discovery, Beckman Res Inst,Dept Diabet & Metab Dis Res, Leslie & Susan Gonda Goldschmied Diabet & Genet R, Duarte, CA 91010 USA
来源
关键词
orphan nuclear receptors; mitogen-activated protein kinases; gene regulation; skeletal muscle; PROLIFERATOR-ACTIVATED RECEPTOR; TRANSCRIPTIONAL COREPRESSOR RIP140; MUSCLE CELL-DIFFERENTIATION; CYTOCHROME-C-OXIDASE; MITOCHONDRIAL BIOGENESIS; SIGNALING PATHWAYS; NUCLEAR RECEPTORS; GENE-EXPRESSION; COACTIVATOR-1-ALPHA PGC-1-ALPHA; OXIDATIVE-METABOLISM;
D O I
10.1152/ajpcell.00033.2011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Murray J, Huss JM. Estrogen-related receptor alpha regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway. Am J Physiol Cell Physiol 301: C630-C645, 2011. First published May 11, 2011; doi: 10.1152/ajpcell.00033.2011.-Myocyte differentiation involves complex interactions between signal transduction pathways and transcription factors. The estrogen-related receptors (ERRs) regulate energy substrate uptake, mitochondrial respiration, and biogenesis and may target structural gene programs in striated muscle. However, ERR alpha's role in regulating myocyte differentiation is not known. ERR alpha and peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha) are coordinately upregulated with metabolic and skeletal muscle-specific genes early in myogenesis. We analyzed effects of ERR alpha overexpression and loss of function in myogenic models. In C2C12 myocytes ERR alpha overexpression accelerated differentiation, whereas XCT790 treatment delayed myogenesis and resulted in myotubes with fewer mitochondria and disorganized sarcomeres. ERR alpha-/- primary myocytes showed delayed myogenesis, resulting in structurally immature myotubes with reduced sarcomeric assembly and mitochondrial function. However, sarcomeric and metabolic gene expression was unaffected or upregulated in ERR alpha-/- cells. Instead, ERR alpha-/- myocytes exhibited aberrant ERK activation early in myogenesis, consistent with delayed myotube formation. XCT790 treatment also increased ERK phosphorylation in C2C12, whereas ERR alpha overexpression decreased early ERK activation, consistent with the opposing effects of these treatments on differentiation. The transient induction of MAP kinase phosphatase-1 (MKP-1), which mediates ERK dephosphorylation at the onset of myogenesis, was lost in ERR alpha-/- myocytes and in XCT790-treated C2C12. The ERR alpha-PGC-1 alpha complex activates the Dusp1 gene, which encodes MKP-1, and ERR alpha occupies the proximal 5' regulatory region during early differentiation in C2C12 myocytes. Finally, treatment of ERR alpha-/- myocytes with MEK inhibitors rescued normal ERK signaling and myogenesis. Collectively, these data demonstrate that ERR alpha is required for normal skeletal myocyte differentiation via modulation of MAP kinase signaling.
引用
收藏
页码:C630 / C645
页数:16
相关论文
共 50 条
  • [31] Protein kinase C epsilon affects mitochondrial function through estrogen-related receptor alpha
    Lu, Na
    Wang, Wenxian
    Liu, Jinsong
    Wong, Chi-Wai
    CELLULAR SIGNALLING, 2011, 23 (09) : 1473 - 1478
  • [32] BAFF activation of the ERK5 MAP kinase pathway regulates B cell survival
    Jacque, Emilie
    Schweighoffer, Edina
    Tybulewicz, Victor L. J.
    Ley, Steven C.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 212 (06): : 883 - 892
  • [33] Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) Signaling Regulates Mitochondrial Biogenesis and Respiration via Estrogen-related Receptor α (ERRα)
    Li, Yang
    He, Lina
    Zeng, Ni
    Sahu, Divya
    Cadenas, Enrique
    Shearn, Colin
    Li, Wei
    Stiles, Bangyan L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (35) : 25007 - 25024
  • [34] ESTROGEN-RELATED RECEPTOR ALPHA MEDIATED PATHWAY AS A POTENTIAL THERAPEUTIC TARGET FOR UTERINE ENDOMETRIAL CANCER
    Kokabu, T.
    Mori, T.
    Matsushima, H.
    Tarumi, Y.
    Yoriki, K.
    Kuroboshi, H.
    Sawada, M.
    Umemura, S.
    Kitawaki, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 179 - 179
  • [35] Revascularization of ischemic skeletal muscle by estrogen-related receptor-γ (vol 110, pg 1087, 2012)
    Matsakas, A.
    Yadav, V
    Lorca, S.
    Evans, R. M.
    Narkar, V. A.
    CIRCULATION RESEARCH, 2012, 111 (10) : E275 - E275
  • [36] Estrogen-related receptor γ regulates expression of 17β-hydroxysteroid dehydrogenase type 1 in fetal growth restriction
    Zhu, Hui
    Huang, Linhuan
    He, Zhiming
    Zou, Zhiyong
    Luo, Yanmin
    PLACENTA, 2018, 67 : 38 - 44
  • [37] Vitellogenin regulates estrogen-related receptor expression by crosstalk with the JH and IIS-TOR signaling pathway in Polyrhachis vicina Roger (Hymenoptera, Formicidae)
    Zhang, Juan-Juan
    Xi, Geng-Si
    Zhao, Jing
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2021, 310
  • [38] PGC-1β regulates mouse carnitine-acylcarnitine translocase through estrogen-related receptor α
    Gacias, Mar
    Perez-Marti, Albert
    Pujol-Vidal, Magdalena
    Marrero, Pedro F.
    Haro, Diego
    Relat, Joana
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 423 (04) : 838 - 843
  • [39] Disruption of the transforming growth factor-β pathway by tolfenamic acid via the ERK MAP kinase pathway
    Zhang, Xiaobo
    Min, Kyung-Won
    Liggett, Jason
    Baek, Seung Joon
    CARCINOGENESIS, 2013, 34 (12) : 2900 - 2907
  • [40] The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor α (ERRα)
    Schreiber, SN
    Knutti, D
    Brogli, K
    Uhlmann, T
    Kralli, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (11) : 9013 - 9018